Medicare Enrolled

Dr. Michelle Ferreira, D.O.

Neurology · Coconut Creek, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
5350 W HILLSBORO BLVD STE 108, Coconut Creek, FL 33073
5619621508
In practice since 2008 (17 years)
NPI: 1902054851 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ferreira from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ferreira? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ferreira

Dr. Michelle Ferreira is a neurology in Coconut Creek, FL, with 17 years in practice. Based on federal Medicare data, Dr. Ferreira performed 16,755 Medicare services across 431 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ferreira received a total of $76,682 from 92 pharmaceutical and/or device companies across 2006 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ferreira is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice▲ Top 6% volume in FL$ $76,682 industry payments

Medicare Practice Summary

Medicare Utilization ↗
16,755
Medicare services
Top 6% in FL for neurology
431
Unique beneficiaries
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~986 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Botox injection, per unit16,005$5$24
Office visit, established patient (30-39 min)455$97$562
Office visit, established patient (20-29 min)96$65$397
Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face48$139$772
New patient office visit (45-59 min)46$128$730
Office visit, established patient, complex (40-54 min)30$136$788
Injection of chemical for paralysis of salivary glands on both sides of mouth29$93$609
New patient office visit, complex (60-74 min)27$169$976
Measurement of brain wave activity (eeg), 61-119 minutes19$347$1,803
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$76,682
Total received (2018-2024)
Avg $10,955/year across 7 years
Top 7% in FL for neurology
92
Companies
2,006
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$49,288 (64.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$26,530 (34.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$863 (1.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,150
2023
$12,351
2022
$26,011
2021
$15,017
2020
$5,817
2019
$6,924
2018
$7,411

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$29,539
Allergan, Inc.
$11,502
Promius Pharma LLC
$3,775
Sunovion Pharmaceuticals Inc.
$3,092
Amneal Pharmaceuticals LLC
$3,061
Teva Pharmaceuticals USA, Inc.
$2,617
Novartis Pharmaceuticals Corporation
$2,126
Amgen Inc.
$1,219
Neurocrine Biosciences, Inc.
$1,190
Medtronic USA, Inc.
$1,073
GENZYME CORPORATION
$941
EMD Serono, Inc.
$861
UCB, Inc.
$812
ACADIA Pharmaceuticals Inc
$717
Biogen, Inc.
$691
Lilly USA, LLC
$681
Lundbeck LLC
$660
Acorda Therapeutics, Inc
$601
US WorldMeds, LLC
$535
Eisai Inc.
$535
PFIZER INC.
$534
AbbVie Inc.
$515
Alexion Pharmaceuticals, Inc.
$502
Egalet US Inc
$478
Kyowa Kirin, Inc.
$463
Allergan Inc.
$404
ARGENX US, INC.
$394
Biohaven Pharmaceutical Holding Company Ltd.
$385
CSL Behring
$368
Supernus Pharmaceuticals, Inc.
$351
Biohaven Pharmaceuticals, Inc.
$341
Adamas Pharmaceuticals, Inc.
$321
MDD US Operations, LLC
$287
Alnylam Pharmaceuticals Inc.
$262
Avanir Pharmaceuticals, Inc.
$237
Medtronic, Inc.
$227
Merz Pharmaceuticals, LLC
$225
Genentech USA, Inc.
$214
HARMONY BIOSCIENCES LLC
$192
Almatica Pharma LLC
$190
Upsher-Smith Laboratories LLC
$188
Octapharma USA, Inc.
$184
Celgene Corporation
$183
Ipsen Biopharmaceuticals, Inc
$179
EISAI INC.
$166
Mallinckrodt Hospital Products Inc.
$162
IMPEL PHARMACEUTICALS INC.
$160
Grifols USA, LLC
$155
Abbott Laboratories
$144
Merz North America, Inc.
$140
Janssen Pharmaceuticals, Inc
$119
UPSHER-SMITH LABORATORIES LLC
$112
SK Life Science, Inc.
$104
Avion Pharmaceuticals
$98
Impax Laboratories, Inc.
$95
MITSUBISHI TANABE PHARMA AMERICA, INC.
$89
Akcea Therapeutics, Inc.
$74
ARBOR PHARMACEUTICALS, INC.
$74
E.R. Squibb & Sons, L.L.C.
$73
ANI Pharmaceuticals, Inc.
$72
Bausch Health US, LLC
$70
Arbor Pharmaceuticals, Inc.
$68
Currax Pharmaceuticals LLC
$65
Boston Scientific Corporation
$55
CATALYST PHARMACEUTICALS, INC.
$52
Vertical Pharmaceuticals, LLC
$50
Neurelis, Inc.
$48
Endo Pharmaceuticals Inc.
$48
AbbVie, Inc.
$46
Silk Road Medical, Inc.
$44
Saol Therapeutics Inc.
$43
Harmony Biosciences LLC
$37
Azurity Pharmaceuticals, Inc.
$27
Takeda Pharmaceuticals U.S.A., Inc.
$25
Cala Health, Inc.
$24
Mallinckrodt Enterprises LLC
$24
Alfasigma USA, Inc.
$23
AstraZeneca Pharmaceuticals LP
$23
SANOFI-AVENTIS U.S. LLC
$20
Otsuka America Pharmaceutical, Inc.
$20
InSightec,Inc
$19
AQUESTIVE THERAPEUTICS, INC.
$19
Ironshore Pharmaceuticals Inc.
$18
Piramal Imaging Limited
$17
NOVARTIS PHARMACEUTICALS CORPORATION
$17
Merck Sharp & Dohme Corporation
$16
Zyla Life Sciences, Inc.
$15
Shire North American Group Inc
$14
Bayer HealthCare Pharmaceuticals Inc.
$14
ASSERTIO THERAPEUTICS, Inc.
$13
JAZZ PHARMACEUTICALS INC.
$13
Dynasplint Systems Inc.
$8
Top 3 companies account for 58.4% of total payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ACTIVA PC · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Aduhelm · Aimovig · Apokyn · Austedo XR · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · Betaseron · Briviact · CALA KIQ · COMIRNATY · CONTRAVE · COPAXONE · DUOPA · DYSPORT · Dhivy · Duopa · Dynasplint · Dysport · EMGALITY · ENROUTE Transcarotid Neuroprotection System · Edarbi · Evrysdi · Exablate · FIRDAPSE · Fycompa · GILENYA · GOCOVRI · GRALISE · Gamunex-C · Gralise · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · Infinity DBS Pulse Generators · JORNAY PM · KESIMPTA · KYNMOBI · LEMTRADA · LONHALA MAGNAIR · LORZONE · LUX-Dx Insertable Cardiac Monitor · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · MYDAYIS · MYOBLOC · Mavenclad · NAMZARIC · NAPRELAN · NASCOBAL · NEURACEQ · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · OCREVUS · ONGENTYS · ONPATTRO · OSMOLEX ER · OXTELLAR XR · Ocrevus · Ongentys · PANZYGA · PAXLOVID · PERCEPT PC BRAINSENSE · PURIFIED CORTROPHIN GEL · Ponvory · QUDEXY XR TOPIRAMATE EXTENDED RELEASE CAPSULES · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RADICAVA · REXULTI · RYTARY · Rystiggo · SOLIRIS · SPINRAZA · SPRAVATO · SPRIX · SUNOSI · SYMPAZAN · Soliris · TECFIDERA · TEGSEDI · TOPIRAMATE Extended Release Capsules · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TRINTELLIX · TROKENDI XR · TYSABRI · Tosymra Sumatriptan Nasal Spray · Trudhesa · Tysabri · UBRELVY · ULTOMIRIS · VALTOCO · VERCISE · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAKIX · Wakix · XEOMIN · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · Zembrace
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (64%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 7% for neurology in FL.

Equivalent to $458 per 100 Medicare services performed
Looking for a neurology in Coconut Creek?
Compare neurologys in the Coconut Creek area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
179
Per 100K population
9.2
County median income
$74,534
Nearest hospital
HCA FLORIDA NORTHWEST HOSPITAL
3.6 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Ferreira is a mixed practice specialist, with above-average Medicare volume (top 6% in FL), and high industry engagement (speaking/promotional, top 7%), with 17 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Ferreira experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Ferreira performed 16,005 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ferreira receive payments from pharmaceutical companies?
Yes. Dr. Ferreira received a total of $76,682 from 92 companies across 2,006 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ferreira's costs compare to other neurologys in Coconut Creek?
Dr. Ferreira's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ferreira) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →